Sleepiness and the Risk of Falling
NCT00383357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2007-09-20
Summary
The purpose of this project is to examine the impact of sleeping pills and waking up in the middle of the night on walking balance and cognitive function, to identify risk factors for falls in older adults. A significant percentage of falls, approximately 33 to 52 percent, occur during the nighttime and morning hours when people are normally sleeping; therefore, it is possible that sleep and sleeping medication related impairments in balance may contribute to this risk.
Conditions
- Aging
- Balance
- Sleep
Interventions
- DRUG
-
zolpidem
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
National Institute on Aging (NIA)
lead NIH
Principal Investigators
-
Kenneth P. Wright, PhD · Department of Integrative Physiology, University of Colorado
-
Danielle J. Frey, PT, MS · Department of Integrative Physiology, University of Colorado
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-08-31
Countries
- United States
Study Locations
More Related Trials
-
Sleep Without Insomnia or The Use of Chronic Hypnotics
NCT03687086 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Chronic Hypnotic Use
NCT01006525 ·Status: COMPLETED
-
Z-Drugs for Sleep Disorders in Alzheimer's Disease
NCT03075241 ·Status: COMPLETED ·Phase: PHASE3
-
Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly
NCT00873379 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
NCT02963181 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects
NCT03892902 ·Status: COMPLETED ·Phase: PHASE1
-
Hypnotic Intake and Motor and Cognitive Performances at High Altitude
NCT02778659 ·Status: COMPLETED ·Phase: NA
-
The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation
NCT02831894 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep and Breathing in the General Population - Chemical Stimuli
NCT04720547 ·Status: COMPLETED ·Phase: PHASE4
-
Zolpidem's Effects on Road Cycling Performance
NCT06800378 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Chronic Hypnotic Use 2
NCT02456532 ·Status: COMPLETED ·Phase: PHASE4
-
Memory Consolidation in Pharmacologically Enhanced Naps
NCT00777829 ·Status: COMPLETED ·Phase: NA
-
Safety of Ramelteon in Elderly Subjects
NCT00568789 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
NCT00386334 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
NCT00816673 ·Status: COMPLETED ·Phase: PHASE2
-
Brief Intervention for Sleep Medication Misuse Among Elderly
NCT06032715 ·Status: RECRUITING ·Phase: NA
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin for Delirium Prophylaxis
NCT02282241 ·Status: WITHDRAWN ·Phase: PHASE4
-
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II
NCT06867549 ·Status: RECRUITING ·Phase: PHASE2
-
Improving Sleep Quality in Heart Failure
NCT03307005 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
NCT01243060 ·Status: COMPLETED ·Phase: NA
-
Insomnia in Older Adults: Impact of Personalized, Diet-Induced Alterations in the Microbiota
NCT03085446 ·Status: COMPLETED ·Phase: NA
-
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
NCT00283790 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Suicidal Ideation Through Insomnia Treatment
NCT01689909 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Sleep Disruption on Drug Response
NCT03680287 ·Status: COMPLETED ·Phase: PHASE2